| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |